Please use this identifier to cite or link to this item:
Title: Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
Authors: Nicholson, KG
Colegate, AE
Podda, A
Stephenson, I
Wood, J
Ypma, E
Zambon, MC
First Published: 16-Jun-2001
Citation: LANCET, 2001, 357 (9272), pp. 1937-1943
Abstract: In 1997, pathogenic avian influenza A/Hong Kong/97 (H5N1) viruses emerged as a pandemic threat to human beings. A non-pathogenic variant, influenza A/Duck/Singapore/97 (H5N3), was identified as a leading vaccine candidate. We did an observer-blind, phase I, randomised trial in healthy volunteers to assess safety, tolerability, and antigenicity of MF59-adjuvanted and non-adjuvanted vaccines.
DOI Link: 10.1016/S0140-6736(00)05066-2
ISSN: 0140-6736
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.